Govt disburses Rs 36,754 cr under PLI schemes

Benchmarks
Nifty23,140.5077.41
FEATURED FUNDS★★★★★
Motilal Oswal Midcap Fund Direct-Growth
5Y Return
20.47 %
Invest Now
Enter search text:
Business News›News›Company›Corporate Trends›Govt disburses Rs 36,754 cr under PLI schemes as on June 30
Read Today's Paper
Govt disburses Rs 36,754 cr under PLI schemes as on June 30
Synopsis
The government has disbursed Rs 36,754 crore to beneficiary companies under the Production Linked Incentive schemes. These schemes have led to actual investment of Rs 2.58 lakh crore in manufacturing capabilities. While attracting investment, they have facilitated exports amounting to Rs 15.53 lakh crore and generated significant employment opportunities. In the pharmaceuticals sector, the scheme has recorded sales exceeding Rs 3.64 lakh crore.
AgenciesThe government has disbursed Rs 36,754 crore to beneficiary companies under the Production Linked Incentive schemes
New Delhi: The government has disbursed Rs 36,754 crore to beneficiary companies under the Production Linked Incentive (PLI) schemes as on June 30 this year, the commerce and industry ministry said on Friday.
The government launched the PLI schemes in 2020 for 14 key sectors, with an approved outlay of Rs 1.91 lakh crore, to enhance India's manufacturing capabilities, attract investment, promote exports, generate employment, and reduce import dependence.
Also Read: Govt set to consider auto PLI applications with Chinese investment after FDI nod
"As on June 30, 2026, the PLI Schemes have resulted in actual investment of Rs 2.58 lakh crore, against which production/sales of Rs 23.79 lakh crore and exports of Rs 15.53 lakh crore have been recorded. These Schemes have led to the employment generation of over 14.57 lakh (direct and indirect) along with Rs 36,754 crore of cumulative incentives disbursed so far," the DPIIT said.
It also said that the pharmaceuticals sector has recorded cumulative sales of over Rs 3.64 lakh crore under the scheme.
The scheme has also enabled the domestic manufacture of 1,931 pharmaceutical products, including 191 bulk drugs manufactured in India for the "first time".
"Major global players such as Siemens, Wipro GE and Philips have participated in technology-transfer projects, enabling domestic manufacture of CT/MRI systems, cath labs and ultrasonography equipment. PLI beneficiaries have generated Rs 6,475 crore in domestic sales, with Rs 560 crore exports and Rs 1,400 crore revenue from implants," it said.
e-PRODUCTION INVESTMENT VISA (e-B4 VISA)
The department for promotion of industry and internal trade (DPIIT) has launched an online module for Indian companies to generate sponsorship letters for inviting foreign professionals for production-related activities under the e-Production Investment Business Visa (e-B-4 Visa) in November 2025.
The launch of this digital platform is a part of a series of reforms that the Government has instituted under the business visa regime for improving the ease of doing business in India.
The e-Production Investment Business registration module was launched on the National Single Window System (NSWS), which can be availed by PLI as well as non-PLI businesses, it said.
"Indian companies can generate digitally signed sponsorship letters for foreign professionals, reducing paperwork and processing delays. An online process has been introduced to generate supplementary Sponsorship Letter generation to declare visits to Additional sites by foreign professionals already issued with a Sponsorship Letter," it added.
Add as a Reliable and Trusted News Source
Add Now!
(You can now subscribe to our WhatsApp channel)
(You can now subscribe to our WhatsApp channel)
Read More News on
Production Linked Incentive schemesPLI schemes disbursed amountgovernment manufacturing incentivesemployment generation PLIIndia production incentivespharmaceuticals sector sales PLIdomestic manufacturing investment Indiaglobal companies in Indiatata steelGovernment of India


Enter search text:
Stories you might be interested in




Leave a Reply